Star Health & Allied Insurance Company Ltd
Star Health & Allied Insurance Company Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Encouraging improvement in loss ratio in Q2 signals positive trend for growth. The company is focused on a long-term strategy to improve Return on Equity (RoE), targeting mid-teens RoE by 2027-2028.
From Star Health & Allied Insurance Company Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Encouraging improvement in loss ratio in Q2 signals positive trend for growth.
- GST exemption on retail health insurance expected to provide strong tailwinds, boosting demand and affordability.
- Fresh business growth robust, with about 50% growth in new policies noted in October.
- Retail health business focus with preferred geographies showing 1.5x faster growth than company average.
- Long-term policies growing significantly; about 13% of policies are long-term with higher value contribution (35-40%).
- Digital channels growing rapidly (~47% YoY fresh premium growth), contributing 20% of fresh business.
- Agency channel remains strong, with 20% growth in fresh business and expanding agent base (~8 lakh agents).
- Continuous portfolio recalibration and pricing discipline expected to support profitable growth.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Star Health & Allied Insurance Company Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Star Health & Allied Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Star Health & Allied Insurance Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.6K Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Star Health & Allied Insurance Company Ltd's management said in earlier quarters
- Q4 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Insurance this season
- Niva Bupa Health (Q2 FY26)
October saw over 50% growth in retail sales, driven by GST reduction from 18% to 0%, enhancing affordability and demand. Key concall takeaways from Niva Bupa…
- ICICI Lombard General Insurance Company Ltd (Q2 FY26)
The company is focused on sustaining an ROE in the range of 18%-20%. Key concall takeaways from ICICI Lombard's Q2 FY26 earnings call — and how it ranks…
- Canara HSBC Life Insurance Company Ltd (Q2 FY26)
Digital business contribution is set to increase, with 99% of current business digitally onboarded and 85% of service requests managed through DIY digital…
- SBI Life Insurance Company Ltd (Q2 FY26)
Online business (primarily via own website) is growing strongly, with individual new business premium up 34% and protection business through this channel up…
Frequently Asked Questions
What were Star Health & Allied Insurance Company Ltd Q2 FY26 results?
Encouraging improvement in loss ratio in Q2 signals positive trend for growth. The company is focused on a long-term strategy to improve Return on Equity (RoE), targeting mid-teens RoE by 2027-2028.
What is Star Health & Allied Insurance Company Ltd share price analysis?
Star Health & Allied Insurance Company Ltd currently shows a neutral. The stock trades at a P/E of 40.3 with a market cap of ₹34,052 Cr. Investors should review the full earnings analysis for detailed insights.
Is Star Health & Allied Insurance Company Ltd planning capital expenditure?
The transcript does not explicitly mention any current or future capex, capital investment, or strategic investment plans by Star Health and Allied Insurance Company Ltd.
Keep Star Health & Allied Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.